| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |